Bioxytran Inc

General ticker "BIXT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $11.6M

Bioxytran Inc does not follow the US Stock Market performance with the rate: -32.3%.

Estimated limits based on current volatility of 5.3%: low 0.09$, high 0.10$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.05$, 0.21$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.03$, 0.13$]

Financial Metrics affecting the BIXT estimates:

  • Negative: Non-GAAP EPS, $ of -0.03 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -4.16 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0.14

Similar symbols

Short-term BIXT quotes

Long-term BIXT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $4.21MM $2.13MM $3.82MM
Operating Income $-4.21MM $-2.13MM $-3.82MM
Non-Operating Income $-0.31MM $-0.52MM $-0.55MM
Interest Expense $0.31MM $0.52MM $0.54MM
R&D Expense $2.01MM $0.98MM $1.15MM
Income(Loss) $-4.53MM $-2.66MM $-4.37MM
Taxes $0.00MM $-0.19MM $-0.09MM
Profit(Loss) $-4.53MM $-2.46MM $-4.28MM
Stockholders Equity $-3.16MM $-2.70MM $-2.43MM
Assets $0.12MM $0.37MM $0.14MM
Operating Cash Flow $-1.70MM $-1.81MM $-0.78MM
Capital expenditure $0.04MM $0.03MM $0.04MM
Investing Cash Flow $-0.04MM $-0.03MM $-0.04MM
Financing Cash Flow $1.76MM $2.06MM $0.55MM
Earnings Per Share* $-0.04 $-0.02 $-0.03

* EPS are Split Adjusted, recent splits may be reflected with a delay.